You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

22 Items

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2011 to June 2012

Document Status: Current
ID: PET 2012-1

Sep 2013

Screening High-Risk Populations for Lung Cancer

Document Status: Archived
ID: 15-10

Apr 2013

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Document Status: Archived
ID: MOAC 1

Nov 2013

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

Document Status: Archived
ID: 2-25

Dec 2013

The Role of Colony-Stimulating Factor (CSF) in Patients Receiving Myelosuppressive Chemotherapy for the Treatment of Cancer

Document Status: Archived
ID: 12-2 Version 2.2003
Version: 2

May 2013

The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Excluding Nasopharynx)

Document Status: Archived
ID: 5-1

Apr 2013

The Role of Octreotide in the Management of Patients with Cancer

Document Status: Archived
ID: 12-7

Jun 2013

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Document Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

Treatment of Chronic Myeloid Leukemia with Imatinib

Document Status: Archived
ID: 6-15

Dec 2013

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

Document Status: Archived
ID: 6-2
Version: 2

Aug 2013